Eli Lilly has received FDA approval for a combo pill called Symbyax to be used for the treatment of treatment-resistant depression.
Symbyax, which combines the ingredients of the antipsychotic Zyprexa (olanzapine) with the antidepressant Prozac (fluoxetine), is approved for patients with major depression who have not responded to two separate trials of different antidepressants.
It was originally approved by the FDA in
Read the rest of this entry
Approval, depression, Gets, Resistant, Symbyax, treatment
Have you been through numerous drug trials without getting relief from your depression? Do antidepressants only work for a short while before “pooping out”? Treatment-resistant depression (TRD) can be very discouraging for those who have it, but there are options that may be able to help you.
One option is electroconvulsive therapy (ECT). While ECT doesn’t come without side-effects, it does bring rapid relief for about 80 percent
Read the rest of this entry
depression, Options, Resistant, treatment
